ATE220912T1 - Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung - Google Patents

Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung

Info

Publication number
ATE220912T1
ATE220912T1 AT96201585T AT96201585T ATE220912T1 AT E220912 T1 ATE220912 T1 AT E220912T1 AT 96201585 T AT96201585 T AT 96201585T AT 96201585 T AT96201585 T AT 96201585T AT E220912 T1 ATE220912 T1 AT E220912T1
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
topical use
skin
Prior art date
Application number
AT96201585T
Other languages
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ATE220912T1 publication Critical patent/ATE220912T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT96201585T 1990-06-01 1991-05-24 Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung ATE220912T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (1)

Publication Number Publication Date
ATE220912T1 true ATE220912T1 (de) 2002-08-15

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96201585T ATE220912T1 (de) 1990-06-01 1991-05-24 Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
AT91912052T ATE151977T1 (de) 1990-06-01 1991-05-24 Therapeutisch wirksame, örtliche anwendung von st1435

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT91912052T ATE151977T1 (de) 1990-06-01 1991-05-24 Therapeutisch wirksame, örtliche anwendung von st1435

Country Status (10)

Country Link
US (1) US5651973A (de)
EP (3) EP0600873B1 (de)
JP (1) JP2625254B2 (de)
AT (2) ATE220912T1 (de)
CA (1) CA2083404C (de)
DE (2) DE69125855T2 (de)
DK (2) DK0600873T3 (de)
ES (2) ES2099747T3 (de)
GR (1) GR3023312T3 (de)
WO (1) WO1991018570A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018570A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Therapeutically effective topical application of st1435
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
WO2010019365A1 (en) * 2008-08-12 2010-02-18 Optimer, Inc. Method of reducing the distortion of the electromagnetic field
CN102753180A (zh) 2009-12-17 2012-10-24 人口委员会股份有限公司 Nestorone*/雌二醇透皮凝胶
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
EP3224410B1 (de) 2014-11-25 2019-06-05 Buckman Laboratories International, Inc Filzkonditionierer und -reiniger

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (de) * 1969-02-13 1970-08-17
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0394429B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend gestoden
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
WO1991018570A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Therapeutically effective topical application of st1435
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
EP0754456A3 (de) 2000-02-02
DE69125855D1 (de) 1997-05-28
EP0754456B1 (de) 2002-07-24
EP0600873B1 (de) 1997-04-23
DK0600873T3 (da) 1997-05-20
DE69133077D1 (de) 2002-08-29
DK0754456T3 (da) 2002-11-11
US5651973A (en) 1997-07-29
DE69125855T2 (de) 1997-07-31
JP2625254B2 (ja) 1997-07-02
CA2083404C (en) 2001-02-20
EP1093816A3 (de) 2003-10-22
EP0754456A2 (de) 1997-01-22
CA2083404A1 (en) 1991-12-02
ES2099747T3 (es) 1997-06-01
EP0600873A4 (de) 1993-09-02
ES2180690T3 (es) 2003-02-16
WO1991018570A1 (en) 1991-12-12
JPH07502253A (ja) 1995-03-09
ATE151977T1 (de) 1997-05-15
GR3023312T3 (en) 1997-08-29
EP0600873A1 (de) 1994-06-15
EP1093816A2 (de) 2001-04-25
DE69133077T2 (de) 2002-11-07

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
SE8406538D0 (sv) Novel derivatives of purine
ES2168273T3 (es) Ligando para el receptor c-kit y metodos de uso del mismo.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2173858T3 (es) Analogos de huperzina a.
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
DK0951553T3 (da) Adenovirus-E4-proteiner til induktion af celledød
KR910005858A (ko) 지방산 요법
AU3024389A (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
IE780497L (en) Broparestrol based therapeutic compositions
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
FI883723A7 (fi) Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IT1291307B1 (it) Composizione farmaceutica atta al trattamento delle patologie neurodegenerative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0754456

Country of ref document: EP

EEFA Change of the company name
EELA Cancelled due to lapse of time